Cargando…
Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269337/ https://www.ncbi.nlm.nih.gov/pubmed/34203268 http://dx.doi.org/10.3390/ijms22136937 |
_version_ | 1783720556794740736 |
---|---|
author | Seyfoori, Amir Shokrollahi Barough, Mahdieh Mokarram, Pooneh Ahmadi, Mazaher Mehrbod, Parvaneh Sheidary, Alireza Madrakian, Tayyebeh Kiumarsi, Mohammad Walsh, Tavia McAlinden, Kielan D. Ghosh, Chandra C. Sharma, Pawan Zeki, Amir A. Ghavami, Saeid Akbari, Mohsen |
author_facet | Seyfoori, Amir Shokrollahi Barough, Mahdieh Mokarram, Pooneh Ahmadi, Mazaher Mehrbod, Parvaneh Sheidary, Alireza Madrakian, Tayyebeh Kiumarsi, Mohammad Walsh, Tavia McAlinden, Kielan D. Ghosh, Chandra C. Sharma, Pawan Zeki, Amir A. Ghavami, Saeid Akbari, Mohsen |
author_sort | Seyfoori, Amir |
collection | PubMed |
description | Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines. |
format | Online Article Text |
id | pubmed-8269337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82693372021-07-10 Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) Seyfoori, Amir Shokrollahi Barough, Mahdieh Mokarram, Pooneh Ahmadi, Mazaher Mehrbod, Parvaneh Sheidary, Alireza Madrakian, Tayyebeh Kiumarsi, Mohammad Walsh, Tavia McAlinden, Kielan D. Ghosh, Chandra C. Sharma, Pawan Zeki, Amir A. Ghavami, Saeid Akbari, Mohsen Int J Mol Sci Review Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines. MDPI 2021-06-28 /pmc/articles/PMC8269337/ /pubmed/34203268 http://dx.doi.org/10.3390/ijms22136937 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Seyfoori, Amir Shokrollahi Barough, Mahdieh Mokarram, Pooneh Ahmadi, Mazaher Mehrbod, Parvaneh Sheidary, Alireza Madrakian, Tayyebeh Kiumarsi, Mohammad Walsh, Tavia McAlinden, Kielan D. Ghosh, Chandra C. Sharma, Pawan Zeki, Amir A. Ghavami, Saeid Akbari, Mohsen Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) |
title | Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) |
title_full | Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) |
title_fullStr | Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) |
title_full_unstemmed | Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) |
title_short | Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) |
title_sort | emerging advances of nanotechnology in drug and vaccine delivery against viral associated respiratory infectious diseases (varid) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269337/ https://www.ncbi.nlm.nih.gov/pubmed/34203268 http://dx.doi.org/10.3390/ijms22136937 |
work_keys_str_mv | AT seyfooriamir emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT shokrollahibaroughmahdieh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT mokarrampooneh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT ahmadimazaher emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT mehrbodparvaneh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT sheidaryalireza emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT madrakiantayyebeh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT kiumarsimohammad emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT walshtavia emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT mcalindenkieland emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT ghoshchandrac emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT sharmapawan emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT zekiamira emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT ghavamisaeid emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid AT akbarimohsen emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid |